(S)-(+)-2-Octanol

CAS No. 6169-06-8

(S)-(+)-2-Octanol( —— )

Catalog No. M37373 CAS No. 6169-06-8

(S)-(+)-2-Octanol is the S-enantiomer of octan-2-ol. Octan-2-ol is involved in the production of nanomaterials and liquid crystal materials.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 30 In Stock
25MG 44 In Stock
50MG 62 In Stock
100MG 86 In Stock
200MG 124 In Stock
500MG 206 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (S)-(+)-2-Octanol
  • Note
    Research use only, not for human use.
  • Brief Description
    (S)-(+)-2-Octanol is the S-enantiomer of octan-2-ol. Octan-2-ol is involved in the production of nanomaterials and liquid crystal materials.
  • Description
    (S)-(+)-2-Octanol is the S-enantiomer of octan-2-ol. Octan-2-ol is involved in the production of nanomaterials and liquid crystal materials.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6169-06-8
  • Formula Weight
    130.23
  • Molecular Formula
    C8H18O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCCC[C@H](C)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Quazolast

    Quazolast (RHC 3988) is a potent mediator release inhibitor used as a control against ragweed antigenic nasal challenge and demonstrates superiority over placebo in preventing nasal congestion and nasal itching following such challenges.

  • Salicylaldoxime

    Salicylaldoxime is an organic compound. This crystalline, colorless solid is a chelator and sometimes used in the analysis of samples containing transition metal ions.

  • 10-O-trans-p-coumaro...

    10-O-trans-p-coumaroylscandoside,posseses Antioxidant activities and vasodilator effects.